SLC31A1 and ovarian cancer: Upregulated expression of CTR1 induced by TF3 enhances the sensitivity of ovarian cancer cells to cisplatin, and the upregulation of CTR1 induced by EGCG mediates cisplatin sensitivity in ovarian cancer cells [25].